Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Regulus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
STA Pharma and Regulus Therapeutics Enter into microRNA Development Agreement 12
Regulus Therapeutics Enters into Collaboration Agreement with AstraZeneca 13
Regulus Therapeutics Expands Agreement With Sanofi-Aventis 14
Licensing Agreements 15
Regulus Therapeutics Amends Licensing Agreement With Sanofi 15
Equity Offering 16
Regulus Therapeutics Plans to Raise USD150 Million in Public Offering of Shares 16
Regulus Therapeutics Raises USD46 Million in Public Offering of Shares 17
Regulus Therapeutics Raises USD82 Million in Public Offering of Shares 19
Regulus Therapeutics Completes Private Placement Of Shares For US$10 Million 21
Regulus Therapeutics Completes Public Offering Of Shares For US$49.2 Million 22
Regulus Announces Partial Exercise Of Underwriter’s Option For IPO For US$51 Million 24
Regulus Therapeutics Completes Private Placement Of Shares For US$25 Million 26
Regulus Therapeutics Inc – Key Competitors 27
Regulus Therapeutics Inc – Key Employees 28
Regulus Therapeutics Inc – Locations And Subsidiaries 29
Head Office 29
Recent Developments 30
Financial Announcements 30
Aug 09, 2018: Regulus Therapeutics reports second quarter 2018 financial results 30
May 10, 2018: Regulus Reports First Quarter 2018 Financial Results and Pipeline Progress 32
Mar 07, 2018: Regulus Reports Fourth Quarter and Year-end 2017 Financial Results and Pipeline Update 33
Nov 07, 2017: Regulus Reports Third Quarter 2017 Financial Results and Recent Events 34
Aug 01, 2017: Regulus Reports Second Quarter 2017 Financial Results and Recent Events 35
May 04, 2017: Regulus Reports First Quarter 2017 Financial Results and Corporate Restructuring 36
Mar 02, 2017: Regulus Reports Fourth Quarter 2016 Financial Results and Pipeline Update 37
Corporate Communications 39
Apr 17, 2018: Kathryn J. Collier Joins Regulus Board Of Directors 39
Jun 13, 2017: Regulus Promotes Mark Deeg, M.D. PhD to Chief Medical Officer 40
Jun 01, 2017: Pascale Witz Joins Regulus Board of Directors 41
Product News 42
Sep 26, 2018: Regulus Provides Pipeline Updates 42
06/12/2017: Regulus Announces Pipeline Update and Advancement on RGLS-4326 43
02/16/2017: Regulus Announces Publication in Nature Communications Identifying miR-17 as a Promising Drug Target for ADPKD 44
Clinical Trials 45
Jun 12, 2017: Regulus Announces Pipeline Update and Advancement on RG-012 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Regulus Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Regulus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
STA Pharma and Regulus Therapeutics Enter into microRNA Development Agreement 12
Regulus Therapeutics Enters into Collaboration Agreement with AstraZeneca 13
Regulus Therapeutics Expands Agreement With Sanofi-Aventis 14
Regulus Therapeutics Amends Licensing Agreement With Sanofi 15
Regulus Therapeutics Plans to Raise USD150 Million in Public Offering of Shares 16
Regulus Therapeutics Raises USD46 Million in Public Offering of Shares 17
Regulus Therapeutics Raises USD82 Million in Public Offering of Shares 19
Regulus Therapeutics Completes Private Placement Of Shares For US$10 Million 21
Regulus Therapeutics Completes Public Offering Of Shares For US$49.2 Million 22
Regulus Announces Partial Exercise Of Underwriter’s Option For IPO For US$51 Million 24
Regulus Therapeutics Completes Private Placement Of Shares For US$25 Million 26
Regulus Therapeutics Inc, Key Competitors 27
Regulus Therapeutics Inc, Key Employees 28
List of Figures
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Regulus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Regulus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10